Get caught up with Contemporary OB/GYN's latest coverage from The Menopause Society Annual Meeting in San Diego, California.
News|Articles|May 14, 2025
What to expect from the 2025 ACOG Annual Clinical and Scientific Meeting
Author(s)Morgan Ebert
Fact checked by: Celeste Krewson, Assistant Editor
A quick look into some of the top sessions occurring at the 2025 ACOG Annual Clinical and Scientific Meeting, being held from May 16-18, 2025, in Minneapolis, Minnesota.
Advertisement
Advertisement
Contemporary Pediatrics will be interviewing several nurse practitioners and presenters throughout the week, so be sure to frequently check our website for updates, data, and recommendations from the conference.
Related to this article
Misread Women’s Health Initiative data sidelined hormone therapy and menopause education, according to Mary Jane Minkin, MD, FACOG.
Susan Reed, MD, on the MsFLASH network's pooled findings, including nonhormonal therapies comparable to low-dose estradiol and CBT for sleep.
Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
Hormone therapy was associated with more frequent, longer migraines in postmenopausal women, but not with greater severity or analgesic use.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Advertisement
Advertisement